MedPath

Hamburgisches Forschungsinstitut für chronisch entzündliche Darmerkrankungen HaFCED e.K.

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Influence of Smoking Cessation or Switching to THS on Disease Activity in IBD Patients.

Conditions
Smoking in IBD Patients
First Posted Date
2022-01-19
Last Posted Date
2022-01-19
Lead Sponsor
HaFCED e.K.
Target Recruit Count
100
Registration Number
NCT05196282

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.